UroMems Initiates First-in-Human Study of Its Smart Implant to Treat Stress Urinary Incontinence

GRENOBLE, France, Nov. 29, 2022 /PRNewswire/ — UroMems, an AdvaMed member and global company developing breakthrough, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it has successfully completed the first-in-human implant of the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) investigational device to treat SUI. This initial clinical study is a key milestone in the development of UroActive. Read more…